Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -4,200 | -5,250 | -2,620 |
| Depreciation Amortization | 1 | 0 | 0 |
| Other Working Capital | 280 | -130 | 130 |
| Other Operating Activity | 619 | 860 | 1,980 |
| Operating Cash Flow | $-3,300 | $-4,520 | $-510 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -9 | 0 | 0 |
| Investing Cash Flow | $-9 | $0 | $0 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 12,630 | 5,820 | 700 |
| Financing Cash Flow | $12,630 | $5,820 | $700 |
| Exchange Rate Effect | -70 | -170 | 4 |
| Beginning Cash Position | 1,310 | 190 | 0 |
| End Cash Position | 10,550 | 1,310 | 190 |
| Net Cash Flow | $9,240 | $1,120 | $190 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,300 | -4,520 | -510 |
| Free Cash Flow | -3,300 | -4,520 | -510 |